Materialise, a leader in 3D printing software and services, has acquired FEops.
FEops is a Belgian company specializing in AI-driven simulation technology for structural heart interventions. This acquisition will enhance Materialise's cardiovascular capabilities by integrating FEops' predictive simulation with Materialise’s Mimics Planner, which is used for 3D planning and anatomical analysis.
The combination aims to advance personalized cardiac care by enabling clinicians to simulate medical device interactions with a patient's unique anatomy, improving the accuracy and efficiency of heart procedures and patient outcomes.
Materialise emphasizes that this integration supports the growing trend of mass personalization in healthcare, allowing for tailored treatment plans based on precise virtual 3D models of patients' anatomies.
This development is significant as structural heart diseases, such as heart valve diseases, present substantial medical and economic challenges worldwide, with millions affected and high associated costs. Materialise's advancements aim to improve the success rates of complex procedures and make personalized healthcare more accessible.
Materialise, with over 30 years of experience, offers a range of software solutions and 3D printing services across various industries, enhancing industrial manufacturing and mass personalization. The company is headquartered in Belgium and operates globally.
